RNXT · RenovoRx, Inc. · Metrics
$1.39
+0.08 (+6.11%)
At close · Oct 27
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$59.12M
Shares
45.13M
Volume · Oct 27
289.42K
Avg daily vol (3M)
797.67K
RNXT metrics
80 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.39
Market cap
$59.12M
Price action
20 metricsPrice change (1W)
+12.9%
Price change (30D)
-15.5%
Price change (3M)
+35.8%
Price change (6M)
+50.6%
Price change (YTD)
+56.0%
Price change (1Y)
+11.0%
Trailing year
Price change (5Y)
-76.4%
52-week high
$2.52
52-week low
$0.73
Change from 52-week high
-48.0%
Change from 52-week low
+78.7%
Annualized volatility
84.9%
Annualized volatility (3M)
108.3%
Beta
1.4
RSI (14D)
45.9
Price vs SMA 50
-15.3%
Price vs SMA 200
+19.5%
Avg volume (3M)
806,587
Relative volume
0.2
Average dollar volume
$1.39M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
45.13M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
29.5×
reciprocal yield 3.4%
P / book
6.5
reciprocal yield 15.4%
FCF yield
-20.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-21.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
2026-11-05
Last earnings
2026-08-12
Profitability
9 metricsGross margin
84.4%
Operating margin
-685.2%
Trailing 12 months
Net margin
-621.7%
Gross profit (TTM)
$1.67M
Operating profit (TTM)
−$13.54M
Net income (TTM)
−$12.29M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
-604.1%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+115.4%
Year over year
Net income growth YoY
—
Revenue (TTM)
$1.98M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+29.3%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-136.8%
Return on assets
-107.1%
Debt / equity
—
Current ratio
5.7
EBITDA (TTM)
—
Free cash flow (TTM)
−$11.94M
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$9.48M
Latest balance sheet
Cash & equivalents
$9.48M
Total assets
$11.47M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$11.87M
Capital expenditures (TTM)
$71,000
R&D (TTM)
$5.63M
SG&A (TTM)
$9.58M
Stock compensation (TTM)
$1.52M
R&D / revenue
284.9%
Stock compensation / revenue
77.0%
Ownership (13F)
9 metrics13F filers
28
13F filer change QoQ
-3
Institutional ownership
20.4%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
14.3%
Private-fund adviser ownership
4.3%
Active holders' share change QoQ
+7.2%
Holder tenure
5.6
Price vs estimated holder cost
-9.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
3.9%
Short interest
3 metricsShort interest
1.9%
Latest settlement · 1.6 days to cover
Days to cover
1.6d
Short-squeeze score
42 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—